Keyphrases
Chemotherapy
100%
Biochemical Mechanism
100%
Cancer Diagnosis
100%
Mechanism of Action
100%
Chemotherapy Agents
100%
Premature Ovarian Insufficiency
100%
Radiotherapy
60%
Cytotoxic Agents
40%
High Incidence
40%
Irradiation
40%
Alkylating Agents
40%
Stem Cells
20%
Survival Rate
20%
Mitotic Inhibitors
20%
Chemotherapy Drugs
20%
Mitochondria
20%
Vascular Endothelial Growth Factor
20%
Bone Marrow Transplantation
20%
Monoclonal Antibody
20%
Cyclophosphamide
20%
Time-to-treatment
20%
Counseling
20%
Threshold Dose
20%
Antibody Targeting
20%
Comprehensive Assessment
20%
Female Fertility
20%
Bevacizumab
20%
Targeted Therapy
20%
Cranium
20%
Topoisomerase Inhibitors
20%
Hypothalamic-pituitary Axis
20%
Granulosa Cells
20%
10-year Survival
20%
Future Fertility
20%
Ovarian Cells
20%
Uterus
20%
Antimetabolites
20%
High-dose Chemotherapy
20%
Pediatric Cancer
20%
Reproductive Age
20%
Biological Agents
20%
Primordial Oocyte
20%
Ovarian Granulosa Cells
20%
Fertility Rate
20%
Fractionation Schedules
20%
Thiotepa
20%
Oocyte Death
20%
Antitumor Antibiotic
20%
Life Decisions
20%
Metabolically Active Cells
20%
Medicine and Dentistry
Cancer Diagnosis
100%
Chemotherapy Agent
100%
Chemotherapy
100%
Primary Ovarian Insufficiency
83%
Radiation Therapy
50%
Oocyte
33%
Alkylating Antineoplastic Agent
33%
Cytotoxic Agent
33%
Granulosa Cell
33%
Malignant Neoplasm
16%
Stem Cell
16%
Survival Rate
16%
DNA Cross Linking
16%
Mitochondrion
16%
Cyclophosphamide
16%
Bone Marrow Transplantation
16%
Monoclonal Antibody
16%
Targeted Therapy
16%
Hypothalamus
16%
Counseling
16%
Pediatric Cancer
16%
Female Fertility
16%
Bevacizumab
16%
Biological Product
16%
Vasculotropin A
16%
Antimetabolite
16%
High Dose Chemotherapy
16%
Topoisomerase Inhibitor
16%
Antineoplastic Antibiotic
16%
Thiotepa
16%
Mitotic Inhibitor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Chemotherapy
100%
Chemotherapy Agent
100%
Premature Ovarian Failure
100%
Cytotoxic Agent
40%
Alkylating Agent
40%
Survival Rate
20%
Vasculotropin A
20%
Monoclonal Antibody
20%
Cyclophosphamide
20%
Biological Product
20%
Antimetabolite
20%
Bevacizumab
20%
DNA Topoisomerase Inhibitor
20%
High Dose Chemotherapy
20%
Antineoplastic Antibiotic
20%
Thiotepa
20%